We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Urethral Length Measurement in Women Undergoing Suburethral Sling Operative Procedure

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01660438
First Posted: August 8, 2012
Last Update Posted: May 20, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Prof. Dr. Volker Viereck, Cantonal Hospital, Frauenfeld
  Purpose
This is a prospective, non-randomized, observational, multicenter study in which urethral length is measured in women with surgically-correctable stress urinary incontinence who undergo a suburethral sling operative procedure.

Condition
Stress Urinary Incontinence

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective, Non-randomized, Observational Study of the Surgical Management of Suburethral Slings in Women With Stress Urinary Incontinence

Resource links provided by NLM:


Further study details as provided by Prof. Dr. Volker Viereck, Cantonal Hospital, Frauenfeld:

Primary Outcome Measures:
  • Cure rate [ Time Frame: 3 months ]
    Patients are classified as 'cured' if the postoperative cough test is negative, the 1-hour pad test is negative (less than 2 g) and the degree of subjective suffering improves to over 90% (VAS score of 0 or 1). All other patients are classified as therapeutic 'failures', even though they may experience marked improvement in one of the parameters compared with their preoperative status.


Secondary Outcome Measures:
  • Pelvic floor sonography [ Time Frame: Pre-operation, day 1 and 3 months ]
  • Residual urine [ Time Frame: Pre-operation, day 1 and 3 months ]
  • Pad test [ Time Frame: Pre-operation and 3 months ]
  • Urethral length measurement [ Time Frame: Intra-operation ]
    Urethral length will be measured using scaled catheters.


Enrollment: 188
Study Start Date: August 2010
Study Completion Date: February 2013
Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
Stress urinary incontinence
Stress urinary incontinence

Detailed Description:
This is a prospective, non-randomized, observational, multicenter study in which urethral length is measured in women with surgically-correctable stress urinary incontinence who undergo a suburethral sling operative procedure. Data will be collected from preoperative urogynecological testing and medical histories. The urethral length will be measured intraoperatively using scaled catheters. Outcome data, including the development of postoperative complications, will be collected at several time intervals.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Women who have surgically-correctable stress urinary incontinence and undergo a suburethral sling operative procedure.
Criteria

Inclusion Criteria:

  1. Patient has objective, demonstrable signs of stress urinary incontinence (SUI), including patients with intrinsic sphincter deficiency (ISD). Objective testing includes: standing stress test, urodynamics evaluation or pad test.
  2. Patient is age 18 or older.
  3. Patient agrees to participate in the study, including completion of all study-related procedures and evaluations, and documents this agreement by signing the Institutional Review Board/Ethics Committee-approved informed consent form.
  4. Patient is able to fill in all questionnaires (based on judgment of investigator)

Exclusion Criteria:

  1. Patient has an associated or suspected neurological disease.
  2. Patient has an active lesion or present injury to perineum or urethra.
  3. Patient has a urethral obstruction.
  4. Patient has significant pelvic organ prolapse (Grade III/IV) requiring surgical treatment.
  5. Patient has current urinary tract infection.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01660438


Locations
Germany
Department of Gynecology and Obstetrics, Lutheran Hospital Hagen-Haspe
Hagen, Germany
Poland
Szpital im M. Madurowicza
Lodz, Poland
Switzerland
Blasenzentrum, Cantonal Hospital
Frauenfeld, Thurgau, Switzerland
Sponsors and Collaborators
Cantonal Hospital, Frauenfeld
Investigators
Principal Investigator: Volker Viereck, Prof. Dr. Cantonal Hospital, Frauenfeld
  More Information

Responsible Party: Prof. Dr. Volker Viereck, Cantonal Hospital, Frauenfeld
ClinicalTrials.gov Identifier: NCT01660438     History of Changes
Other Study ID Numbers: TVT 112010
First Submitted: August 6, 2012
First Posted: August 8, 2012
Last Update Posted: May 20, 2016
Last Verified: May 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Keywords provided by Prof. Dr. Volker Viereck, Cantonal Hospital, Frauenfeld:
Stress urinary incontinence
Suburethral sling

Additional relevant MeSH terms:
Urinary Incontinence
Enuresis
Urinary Incontinence, Stress
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms
Behavioral Symptoms
Elimination Disorders
Mental Disorders